{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:16:45Z","timestamp":1772615805545,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00415-020-09819-y","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T11:03:08Z","timestamp":1586948588000},"page":"2239-2244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Parkinsonism as a late presentation of lymphomatosis cerebri following high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma"],"prefix":"10.1007","volume":"267","author":[{"given":"Sarah","family":"Merrill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Mauler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent R.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Raghunathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose F.","family":"Leis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej M.","family":"Mrugala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"issue":"6","key":"9819_CR1","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.hoc.2016.07.013","volume":"30","author":"J Carnevale","year":"2016","unstructured":"Carnevale J, Rubenstein JL (2016) The challenge of primary central nervous system lymphoma. Hematol Oncol Clin N Am 30(6):1293\u20131316","journal-title":"Hematol Oncol Clin N Am"},{"issue":"13","key":"9819_CR2","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1182\/blood-2015-10-636340","volume":"127","author":"AJ Ferreri","year":"2016","unstructured":"Ferreri AJ, Illerhaus G (2016) The role of autologous stem cell transplantation in primary central nervous system lymphoma. Blood 127(13):1642\u20131649","journal-title":"Blood"},{"issue":"12","key":"9819_CR3","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1038\/leu.2017.170","volume":"31","author":"B Kasenda","year":"2017","unstructured":"Kasenda B et al (2017) High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group. Leukemia 31(12):2623\u20132629","journal-title":"Leukemia"},{"issue":"3","key":"9819_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/annonc\/mdv002","volume":"26","author":"B Kasenda","year":"2015","unstructured":"Kasenda B et al (2015) Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma\u2014a long-term follow-up study. Ann Oncol 26(3):608\u2013611","journal-title":"Ann Oncol"},{"issue":"2","key":"9819_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000017116","volume":"10","author":"R Bakshi","year":"1999","unstructured":"Bakshi R et al (1999) Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disord 10(2):152\u2013157","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"9819_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13244-019-0726-6","volume":"10","author":"ML White","year":"2019","unstructured":"White ML et al (2019) Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential. Insights Imaging 10(1):46","journal-title":"Insights Imaging"},{"issue":"3","key":"9819_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11060-006-9192-3","volume":"80","author":"S Partap","year":"2006","unstructured":"Partap S, Spence AM (2006) Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man. J Neurooncol 80(3):305\u2013307","journal-title":"J Neurooncol"},{"issue":"12","key":"9819_CR8","doi-asserted-by":"publisher","first-page":"e0189897","DOI":"10.1371\/journal.pone.0189897","volume":"12","author":"S Bajaj","year":"2017","unstructured":"Bajaj S et al (2017) Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: a systematic review and meta-analysis. PLoS ONE 12(12):e0189897","journal-title":"PLoS ONE"},{"key":"9819_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.007","volume":"58","author":"J Wang","year":"2019","unstructured":"Wang J et al (2019) Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease. Parkinsonism Relat Disord 58:3\u20138","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"9819_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrneurol.2015.61","volume":"11","author":"AD Korczyn","year":"2015","unstructured":"Korczyn AD (2015) Vascular parkinsonism\u2014characteristics, pathogenesis and treatment. Nat Rev Neurol 11(6):319\u2013326","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"9819_CR11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"SM Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad SM et al (2017) Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression. Brain 140(7):1959\u20131976","journal-title":"Brain"},{"issue":"Suppl 1","key":"9819_CR12","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson DW (2018) Neuropathology of Parkinson disease. Parkinsonism Relat Disord 46(Suppl 1):S30\u2013S33","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"9819_CR13","doi-asserted-by":"publisher","first-page":"e14367","DOI":"10.1097\/MD.0000000000014367","volume":"98","author":"MN Kerbauy","year":"2019","unstructured":"Kerbauy MN et al (2019) Diffuse large B-cell lymphoma of the central nervous system presenting as \"lymphomatosis cerebri\" and dementia in elderly man: case report and review of the literature. Medicine (Baltimore) 98(6):e14367","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"9819_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40644-017-0128-2","volume":"17","author":"H Yu","year":"2017","unstructured":"Yu H et al (2017) Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features. Cancer Imaging 17(1):26","journal-title":"Cancer Imaging"},{"issue":"6","key":"9819_CR15","first-page":"394","volume":"32","author":"TK Jain","year":"2013","unstructured":"Jain TK et al (2013) Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings. Rev Esp Med Nucl Imagen Mol 32(6):394\u2013396","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"1","key":"9819_CR16","first-page":"209","volume":"43","author":"JX Gao","year":"2019","unstructured":"Gao JX et al (2019) Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson's disease. Int J Mol Med 43(1):209\u2013220","journal-title":"Int J Mol Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-09819-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T08:15:32Z","timestamp":1618474532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-09819-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["9819"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09819-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"28 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No conflicts of interest for all authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"For this type of research consent is not required, however we have requested a consent from patient\u2019s family and it was granted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}}]}}